Galapagos NV's Total Assets for the quarter that ended in Dec. 2023 was $4,751.8 Mil.
During the past 12 months, Galapagos NV's average Total Assets Growth Rate was 5.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 6.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 32.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 24.90% per year.
During the past 13 years, Galapagos NV's highest 3-Year average Total Assets Growth Rate was 165.10%. The lowest was -13.60%. And the median was 13.50%.
The historical data trend for Galapagos NV's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Galapagos NV's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Galapagos NV's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Galapagos NV Total Assets Related Terms
Thank you for viewing the detailed overview of Galapagos NV's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GLPG has been successfully added to your 